Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Veterinary medicines
Search for medicinal products
Search for packages
ATC tree
Print
ABATIXENT
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1804878
Name of medicinal product:
ABATIXENT
Active substances:
Apixaban
Estonian
,
English
,
Latin
ATC code:
B01AF02
Dosage form:
film-coated tablet
Route of administration:
oral use
Strengh:
5mg
Amount in package:
20TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age >= 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated September 15, 2021)
Package information leaflet (PIL):
EST
(last updated November 16, 2021)
Labelling:
(last updated September 15, 2021)
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Sandoz Pharmaceuticals d.d.
Marketing authorization number:
1037721
Marketing authorization issued on:
September 15, 2021
Marketing authorization expires on:
September 15, 2026
Marketing authorization procedure type:
Decentralised
Prices
Reference price:
Under reference price:
Reference price of daily dose:
Entry/Changing date: September 14, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here